A fully humanized IgG-like bispecific antibody for effective dual targeting of CXCR3 and CCR6.
Chemokines and their receptors are pivotal for the trafficking of leukocytes during immune responses, and host defense. However, immune cell migration also contributes to a wide variety of autoimmune and chronic inflammatory diseases. Compelling evidence suggests that both CXCR3 and CCR6 chemokine r...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0184278&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850230239461900288 |
|---|---|
| author | Remy Robert Laurent Juglair Ee X Lim Caroline Ang Carl J H Wang Gregor Ebert Olan Dolezal Charles R Mackay |
| author_facet | Remy Robert Laurent Juglair Ee X Lim Caroline Ang Carl J H Wang Gregor Ebert Olan Dolezal Charles R Mackay |
| author_sort | Remy Robert |
| collection | DOAJ |
| description | Chemokines and their receptors are pivotal for the trafficking of leukocytes during immune responses, and host defense. However, immune cell migration also contributes to a wide variety of autoimmune and chronic inflammatory diseases. Compelling evidence suggests that both CXCR3 and CCR6 chemokine receptors play crucial roles in the migration of pathological Th1 and Th17 cells during the course of certain inflammatory diseases. The use of two or more receptors by pathogenic cells may explain why targeting of individual receptors has proven disappointing in the clinic. We therefore hypothesized that simultaneous targeting of both CXCR3 and CCR6 with a bispecific antibody (BsAb) might result in decreased chemotaxis and/or specific depletion of pro-inflammatory T cell subsets. In this study, we designed and characterized a fully humanized BsAb. We show that the BsAb binds to both chemokine receptors, as demonstrated by Flow Cytometry and Surface Plasmon Resonance analysis. Furthermore, we demonstrate that the BsAb effectively blocks cell chemotaxis and induces specific antibody-dependent cell-mediated cytotoxicity (ADCC) in vitro. Therefore, we propose that dual targeting of CXCR3 and CCR6 with a fully humanized BsAb may display a potent interventional approach for the treatment of inflammatory and autoimmune diseases. |
| format | Article |
| id | doaj-art-8708c0d0b60b4ff4808743979a159753 |
| institution | OA Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2017-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-8708c0d0b60b4ff4808743979a1597532025-08-20T02:03:55ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01129e018427810.1371/journal.pone.0184278A fully humanized IgG-like bispecific antibody for effective dual targeting of CXCR3 and CCR6.Remy RobertLaurent JuglairEe X LimCaroline AngCarl J H WangGregor EbertOlan DolezalCharles R MackayChemokines and their receptors are pivotal for the trafficking of leukocytes during immune responses, and host defense. However, immune cell migration also contributes to a wide variety of autoimmune and chronic inflammatory diseases. Compelling evidence suggests that both CXCR3 and CCR6 chemokine receptors play crucial roles in the migration of pathological Th1 and Th17 cells during the course of certain inflammatory diseases. The use of two or more receptors by pathogenic cells may explain why targeting of individual receptors has proven disappointing in the clinic. We therefore hypothesized that simultaneous targeting of both CXCR3 and CCR6 with a bispecific antibody (BsAb) might result in decreased chemotaxis and/or specific depletion of pro-inflammatory T cell subsets. In this study, we designed and characterized a fully humanized BsAb. We show that the BsAb binds to both chemokine receptors, as demonstrated by Flow Cytometry and Surface Plasmon Resonance analysis. Furthermore, we demonstrate that the BsAb effectively blocks cell chemotaxis and induces specific antibody-dependent cell-mediated cytotoxicity (ADCC) in vitro. Therefore, we propose that dual targeting of CXCR3 and CCR6 with a fully humanized BsAb may display a potent interventional approach for the treatment of inflammatory and autoimmune diseases.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0184278&type=printable |
| spellingShingle | Remy Robert Laurent Juglair Ee X Lim Caroline Ang Carl J H Wang Gregor Ebert Olan Dolezal Charles R Mackay A fully humanized IgG-like bispecific antibody for effective dual targeting of CXCR3 and CCR6. PLoS ONE |
| title | A fully humanized IgG-like bispecific antibody for effective dual targeting of CXCR3 and CCR6. |
| title_full | A fully humanized IgG-like bispecific antibody for effective dual targeting of CXCR3 and CCR6. |
| title_fullStr | A fully humanized IgG-like bispecific antibody for effective dual targeting of CXCR3 and CCR6. |
| title_full_unstemmed | A fully humanized IgG-like bispecific antibody for effective dual targeting of CXCR3 and CCR6. |
| title_short | A fully humanized IgG-like bispecific antibody for effective dual targeting of CXCR3 and CCR6. |
| title_sort | fully humanized igg like bispecific antibody for effective dual targeting of cxcr3 and ccr6 |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0184278&type=printable |
| work_keys_str_mv | AT remyrobert afullyhumanizedigglikebispecificantibodyforeffectivedualtargetingofcxcr3andccr6 AT laurentjuglair afullyhumanizedigglikebispecificantibodyforeffectivedualtargetingofcxcr3andccr6 AT eexlim afullyhumanizedigglikebispecificantibodyforeffectivedualtargetingofcxcr3andccr6 AT carolineang afullyhumanizedigglikebispecificantibodyforeffectivedualtargetingofcxcr3andccr6 AT carljhwang afullyhumanizedigglikebispecificantibodyforeffectivedualtargetingofcxcr3andccr6 AT gregorebert afullyhumanizedigglikebispecificantibodyforeffectivedualtargetingofcxcr3andccr6 AT olandolezal afullyhumanizedigglikebispecificantibodyforeffectivedualtargetingofcxcr3andccr6 AT charlesrmackay afullyhumanizedigglikebispecificantibodyforeffectivedualtargetingofcxcr3andccr6 AT remyrobert fullyhumanizedigglikebispecificantibodyforeffectivedualtargetingofcxcr3andccr6 AT laurentjuglair fullyhumanizedigglikebispecificantibodyforeffectivedualtargetingofcxcr3andccr6 AT eexlim fullyhumanizedigglikebispecificantibodyforeffectivedualtargetingofcxcr3andccr6 AT carolineang fullyhumanizedigglikebispecificantibodyforeffectivedualtargetingofcxcr3andccr6 AT carljhwang fullyhumanizedigglikebispecificantibodyforeffectivedualtargetingofcxcr3andccr6 AT gregorebert fullyhumanizedigglikebispecificantibodyforeffectivedualtargetingofcxcr3andccr6 AT olandolezal fullyhumanizedigglikebispecificantibodyforeffectivedualtargetingofcxcr3andccr6 AT charlesrmackay fullyhumanizedigglikebispecificantibodyforeffectivedualtargetingofcxcr3andccr6 |